Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
Open | $2.01 |
Close | $2.06 |
Volume / Avg. | 24.95K / 58.85K |
Day Range | 2.01 - 2.10 |
52 Wk Range | 1.17 - 8.82 |
Market Cap | $32.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 4.92% |
Days to Cover | 24.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acurx Pharmaceuticals (NASDAQ:ACXP) through any online brokerage.
Other companies in Acurx Pharmaceuticals’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Aligos Therapeutics (NASDAQ:ALGS) and Bolt Biotherapeutics (NASDAQ:BOLT).
There is no analysis for Acurx Pharmaceuticals.
Acurx Pharmaceuticals has a consensus price target of $12.67.
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $2.07 last updated July 5, 2024 at 8:52 AM EDT.
There are no upcoming dividends for Acurx Pharmaceuticals.
Acurx Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Acurx Pharmaceuticals.
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.